EFFECTIVENESS OF MECCNU, PROCARBAZINE AND VINCRISTINE IN TREATMENT OF NON-IRRADIATED MALIGNANT GLIOMAS

被引：0
|
作者：
AVELLANOSA, AM [1 ]
HIGBY, DJ [1 ]
WEST, CR [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 47 条
  • [41] Malignant gliomas can be converted to non-proliferating glial cells by treatment with a combination of small molecules
    Oh, Jinsoo
    Kim, Yongbo
    Baek, Daye
    Ha, Yoon
    ONCOLOGY REPORTS, 2019, 41 (01) : 361 - 368
  • [42] Treatment Outcome Results from the Bulgarian Acromegaly Database: Adjuvant Dopamine Agonist Therapy is Efficient in Less than One Fifth of Non-irradiated Patients
    Vandeva, S.
    Elenkova, A.
    Natchev, E.
    Kirilov, G.
    Tcharaktchiev, D.
    Yaneva, M.
    Kalinov, K.
    Marinov, M.
    Hristozov, K.
    Kamenov, Z.
    Orbetzova, M.
    Gerenova, J.
    Tsinlikov, I.
    Zacharieva, S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2015, 123 (01) : 66 - 71
  • [43] Loss to Follow-Up for Radiation Treatment After Resection of Metastatic Brain Tumors: Analysis of a Non-Irradiated Cohort from a Private Insurance Database
    Haider, Ghani
    Dadey, David Yaw Amoah
    Rodrigues, Adrian
    Pollom, Erqi
    Adler, John R.
    Veeravagu, Anand
    NEUROSURGERY, 2023, 69 : 174 - 175
  • [44] Non-conventional fotemustine schedule as second-line treatment in recurrent malignant gliomas: Survival across disease and treatment subgroup analysis and review of the literature
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Grassi, Massimiliano
    Salvati, Maurizio
    D'Elia, Alessandro
    Buttarelli, Francesca
    Ferrara, Carla
    Tomao, Silverio
    Bianco, Vincenzo
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (01) : 58 - 66
  • [45] CARBOPLATIN AND VINCRISTINE AS TREATMENT FOR PROGRESSIVE HYPOTHALAMIC/OPTIC PATHWAY GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND RISK OF SECOND MALIGNANT NEOPLASMS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
    Ater, Joann
    Zhou, Tianni
    Holmes, Emiko
    Booth, Timothy
    Freyer, David
    Packer, Roger
    Vezina, Gilbert
    Wisoff, Jeffery
    Pollack, Ian F.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1077 - 1078
  • [46] The cost-effectiveness of rituximab, cyclophosphamide, vincristine and prednisolone (RCVP) compared with CVP for the treatment of follicular non-Hodgkin's lymphoma (NHL) in the UK.
    Lewis, Gavin
    Marcus, Robert E.
    Proctor, Stephen J.
    Gyldmark, Marlene
    Creeden, James
    Aultman, Rick
    Jost, Fred
    BLOOD, 2006, 108 (11) : 107A - 107A
  • [47] TREATMENT OF INTENSIVELY PRETREATED LOW-GRADE MALIGNANT NON-HODGKIN LYMPHOMAS WITH LOW DOSAGE, CONTINUOUS INFUSION OF VINCRISTINE, DOXORUBICIN, AND HIGH-DOSAGE DEXAMETHASONE (VAD)
    MAUBACH, PA
    EMMERICH, B
    HERBERGER, G
    RASTETTER, J
    BLUT, 1986, 53 (03): : 220 - 221
12345